MARKET

AYAUF

AYAUF

Artrya Ltd
OTCPK
2.590
NaN%
Closed 09:30 10/26 EDT
OPEN
--
PREV CLOSE
2.590
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.590
52 WEEK LOW
2.590
MARKET CAP
423.81M
P/E (TTM)
-22.0613
1D
5D
1M
3M
1Y
5Y
1D
*Artrya Price Target Cut 8.5% to A$5.40/Share by Barrenjoey
Dow Jones · 6h ago
*Artrya Target Price Cut 28% to A$4.30/Share by Bell Potter>AYA.AU
Dow Jones · 8h ago
*Artrya Started With A$4.25/Share Target Price by Morgans>AYA.AU
Dow Jones · 9h ago
*Artrya Started at Spec Buy by Morgans >AYA.AU
Dow Jones · 9h ago
About AYAUF
Artrya Limited is a medical technology company. The Company is engaged in development and commercialization of its patented artificial intelligence (AI) platform that detects, diagnoses, and helps address coronary artery. It partners with clinics receiving chest pain patients to deliver new models of cardiovascular care based on AI. Easily integrate plaque features of high prognostic value into the evaluation of coronary artery disease. Its Artrya Salix is a computed tomography coronary angiography (CCTA) image analysis solution that enables physicians with AI to identify and analyze the extent and type of arterial plaque. This solution uses no external reading teams to validate cardiac scan data, allowing physicians direct control of their AI-supported patient scans. Its Artrya Salix assists physicians in the rapid and convenient analysis of cardiac CT scans to screen patients at risk of heart attack.

Webull offers Artrya Ltd stock information, including OTCPK: AYAUF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYAUF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AYAUF stock methods without spending real money on the virtual paper trading platform.